- All
- PDT School
- Plenary Lecture & Invited Lecture
- Photothermal Therapy
- Chinese Clinical Application
- Immunotherapy of Skin Cancers
- New PDT Activation Sources
- ROS and Explicit Dosimetry
- Immunotherapy of Skin Diseases
- PDT Dosimetry and Interstitial Delivery
- Antimicrobial PDT/Infectious Diseases
- Global health & Low-cost PDT
- Brain
- Urology
- Rising Star Presentations
- Dermatology & Gynecology
- Gynecology
- Gastroenterology and Hepatology
- Head and neck diseases
- Nanotechnology & Oncology
- Novel photosensitizer and Nanotechnology
- lmmunology
- Respirology
- Oral and Nasopharyngeal Diseases
- Oncology
- Dermatology
- All
- 2025-06-10 [Tuesday]
- 2025-06-11 [Wednesday]
- 2025-06-12 [Thursday]
- 2025-06-13 [Friday]
- 2025-06-14 [Saturday]
- 2025-06-15 [Sunday]
- All
- Auditorium 3F
- Yellow River Hall, 3F
- 3B
- 3CD
- 3HIJ
- Front Lobby of the Auditorium
- Pearl Hall 7F
2025-06-13 Friday
Yellow River Hall, 3F (UTC+8)
| NO. | Beijing Time (UTC+8) | Type | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|
| 1 | 08:15-08:45 | Plenary Lecture |
Adventures while Attempting Clinical Translation of Photodynamic Therapy |
Luis Arnaut | University of Coimbra |
| 2 | 08:45-09:05 | Invited Lecture |
Photodynamic Therapy in Recurrent or Residual Disease of Nasopharyngeal Carcinoma after Standard Therapy in Sardjito General Hospital Indonesia |
Sagung Rai Indrasari | Otorhinolaryngology Head and Neck Surgery Department Faculty of Medicine Universitas Gadjah Mada / Sardjito Hospital |
| 3 | 09:05-09:25 | Invited Lecture |
Application of mild local hyperthermia to treat HPV related mucocutaneous infections and beyound |
Xinghua Gao | the first Hospital of China Medical University |
| 4 | 09:25-09:40 | Comment |
Q&A |
||
| NO. | Beijing Time (UTC+8) | Type | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|---|
| 1 | 10:15-10:32 | Oral Presentation |
Regional differences in patent examination standards for photodynamic therapy (PDT) ——Empirical analysis based on patents of treatment methods for bladder cancer |
Zhixin He | Zhixin & Partners Law Firm Limited |
| 2 | 10:32-10:49 | Oral Presentation |
Analysis of the Results of intravesical perfusion Therapy Combined with Immediate or non-immediate hematoporphyrin intravesical perfusion photodynamic therapy after TURBT for Non-muscle-invasive Bladder Cancer |
Linjun Hu | Cancer Hospital of Huanxing, Chaoyang District, Beijing |
| 3 | 10:49-11:06 | Oral Presentation |
Analysis of the Relationship between the Number of hematoporphyrin intravesical perfusion photodynamic therapy Combined with intravesical perfusion Therapy with Tumor Recurrence and Progression in Non-muscle-invasive Bladder Cancer |
Chengming Xie | Cancer Hospital of Huanxing, Chaoyang District, Beijing |
| 4 | 11:06-11:23 | Oral Presentation |
Comparison of Immediate Bladder Photodynamic Therapy and Non-Immediate Therapy in Non-Muscle-Invasive Bladder Cancer: A Single-Center Retrospective Clinical Study |
Jianyong Liu | shenzhen cancer hospital |
| 5 | 11:23-11:40 | Oral Presentation |
Study on prevention of recurrence of NMIBC patients who failed BCG vaccine treatment by hematoporphyrin intravesical perfusion photodynamic therapy combined with intravesical perfusion therapy |
Linjun Hu | Cancer Hospital of Huanxing, Chaoyang District, Beijing |
| 6 | 11:40-11:57 | Oral Presentation |
Photodynamic Therapy Combined with Intravesical Chemotherapy in Non-Muscle-Invasive Bladder Cancer |
Jianyong Liu | shenzhen cancer hospital |
| 7 | 11:57-12:14 | Oral Presentation |
Retrospective study of photodynamic therapy combined with intravesical instillation of pirarubicin in the treatment of high-risk nonmuscular invasive bladder cancer |
Xiang Wang |
